RA Capital Healthcare Fund LP Plans to Sell Sionna Therapeutics Common Stock

RA Capital Healthcare Fund LP, a director and 10% stockholder of Sionna Therapeutics, Inc., has filed a Form 144 notice indicating its intent to sell 14,116 shares of Sionna Therapeutics common stock. The shares were acquired on February 2, 2022, through a private transaction. The planned sale is expected to occur on October 24, 2025, with an aggregate market value of approximately $553,488.36. The sale will be facilitated through BTIG, LLC. There are no recent transactions to report in the past three months.